Photo of Mike Garcia
R United States House · District 27 · California

Rep. Mike Garcia

Compare
Total votes
2,168
all sessions
Attendance
97%
55 missed
Near the chamber average
With party
91%
of cast votes
Lower than 85% of chamber peers
Bipartisan score
5%
crosses aisle rarely
Higher than 84% of chamber peers
Sponsored
375
bills & resolutions
Lower than 87% of chamber peers
Committees
0
assignments
375 bills and resolutions

Sponsored bills

Total
375
Primary
36
Co-sponsor
339
This page
375
matching current filters
Co-sponsor HRES 352
In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 19
In committee · United States House · Co-sponsor
Lower Costs, More Cures Act of 2021

Lower Costs, More Cures Act of 2021 This bill establishes and modifies several programs and requirements to address prescription drug prices. The bill modifies provisions under Medicare and Medicaid relating to prescription drug coverage and price transparency. Among other changes, the bill requires the Centers for Medicare & Medicaid Services to publish certain information, as reported by pharmacy benefit managers (PBMs), relating to generic dispensing rates, drug discounts and rebates, and payments between PBMs, health plans, and pharmacies; caps annual out-of-pocket spending under the Medicare prescription drug benefit; allows prescription drug plan sponsors under the Medicare prescription drug benefit to offer additional plans in a region; requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with PBMs under Medicaid; and allows states to include in the Medicaid Drug Rebate Program covered outpatient drugs that are provided as part of physician or outpatient hospital services. The bill also generally modifies other provisions relating to the regulation and costs of generic and brand-name drugs. Among other changes, the bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product; permanently allows high deductible health plans to waive deductibles for insulin and associated products; and establishes the position of Chief Pharmaceutical Negotiator in the Office of the U.S. Trade Representative.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2718
In committee · United States House · Co-sponsor
Maximum Pressure Act

Maximum Pressure Act This bill expands sanctions and economic penalties on Iran. It also restricts the President from unilaterally lifting or waiving the sanctions or penalties and increases congressional oversight of them. Specifically, the bill requires the President to impose visa- and asset-blocking sanctions. Additionally, it modifies existing sanctions, including by (1) providing statutory authority for executive orders imposing sanctions; (2) applying sanctions to additional sectors of Iran's economy; and (3) broadening sanctionable conduct to cover, for example, assisting Iran with the acquisition of ballistic missiles and the complicity of Iranian officials in human rights violations in specified countries. The bill also requires reporting on licenses that authorize activities subject to sanctions. The bill prohibits U.S. representatives at the International Monetary Fund from voting to allow Iran's access to special drawing rights (a currency support tool) and places restrictions on financial transactions with Iran. The restrictions include requiring domestic financial institutions to implement special measures with respect to foreign financial institutions that conduct significant transactions connected to the Instrument in Support of Trade Exchanges (a European mechanism that bypasses U.S. sanctions when carrying out trade with Iran). The Department of State must maintain the Islamic Revolutionary Guard Corps' designation as a terrorist organization and must designate Ansharallah (or Houthis), which operates in Syria, as a foreign terrorist organization. The bill also requires reports on U.S. sanctions concerning Iran, the status of Iran's nuclear weapons program, and other matters.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 2209
In committee · United States House · Co-sponsor
Stopping Overdoses of Fentanyl Analogues Act

Stopping Overdoses of Fentanyl Analogues Act This bill adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

In committee Oct 19, 2021 1 co-sponsor
Co-sponsor HR 5586
In committee · United States House · Co-sponsor
Prohibiting IRS Financial Surveillance Act

Prohibiting IRS Financial Surveillance Act This bill prohibits the Department of the Treasury from requiring a financial institution to report the transfers into and out of a financial account. This prohibition does not apply to laws or regulations in effect on October 1, 2021.

In committee Oct 15, 2021 1 co-sponsor
Co-sponsor HR 5437
In committee · United States House · Co-sponsor
Reach 871 Congressional Gold Medal Act

Reach 871 Congressional Gold Medal Act This bill provides for the award of a Congressional Gold Medal to the Reach 871 aircrew, commonly known as Reach 871, in recognition of their bravery and outstanding service during Operation Allies Refuge.

In committee Sep 30, 2021 1 co-sponsor
Co-sponsor HR 2748
In committee · United States House · Co-sponsor
Israel Relations Normalization Act of 2021

Israel Relations Normalization Act of 2021 This bill requires the Department of State to take certain actions promoting the normalization of relations between Israel, Arab states, and other relevant countries and regions. Specifically, the State Department must develop a strategy on expanding and strengthening the Abraham Accords (the term used to refer collectively to agreements between Israel and the United Arab Emirates and between Israel and Bahrain marking the public normalization of relations between the two Arab countries and Israel). The strategy must include a description of how the U.S. government will encourage further normalization of relations with Israel. In addition, the State Department must report on options for U.S. international efforts to promote the strengthening of ties between Israel, Arab states, and other relevant countries and regions. The State Department must also report on the status of the normalization of relations with Israel, including information on (1) laws that punish individuals for people-to-people relations with Israelis (i.e., anti-normalization laws), and (2) evidence of steps taken by Arab governments toward permitting or encouraging normalized relations between their citizens or residents and Israeli citizens.

In committee Sep 30, 2021 1 co-sponsor
Co-sponsor HR 5326
In committee · United States House · Co-sponsor
Chinese Military and Surveillance Company Sanctions Act of 2021

Chinese Military and Surveillance Company Sanctions Act of 2021 This bill requires the President to impose property-blocking sanctions on Communist Chinese military companies upon certain findings. Specifically, if the President determines that imposing sanctions on a foreign person would address certain threats related to the financing of Chinese Communist military companies, the President must impose sanctions on that person provided that the person is identified (1) as a Communist Chinese military company in a specified report to Congress or in a November 17, 2020, executive order, or (2) by the Department of the Treasury as having engaged in transactions in the publicly traded securities (or derivatives) of a Communist Chinese military company.

In committee Sep 22, 2021 1 co-sponsor
Co-sponsor HCONRES 50
In committee · United States House · Co-sponsor
Expressing the sense of the Congress that the withdrawal of American Forces from the country of Afghanistan does not undermine or diminish the sacrifice, efforts, and accomplishments of our members of the Armed Forces, diplomats, humanitarians, allies, and partners.

This concurrent resolution expresses the sense of Congress that the men and women who undertook efforts in Afghanistan over the years have provided heroic service to the country and the peace experienced by our country is a direct result of the actions of our service members, diplomats, and humanitarians. The concurrent resolution also expresses that veterans who feel stress, anger, or disappointment over the end of operations in Afghanistan should seek resources and reach out to friends, mentors, and caregivers.

In committee Sep 14, 2021 1 co-sponsor
Showing 291 to 300 of 375 bills
Previous 1 … 29 30 31 … 38 Next